Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3020 |
|
Actual shortage: | 236 (8%) | |
Anticipated shortage: | 18 (1%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2757 (91%) | |
Discontinuation Reports |
356 |
|
To be discontinued: | 22 (6%) | |
Discontinued: | 334 (94%) | |
Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
29 (11%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-GABAPENTIN | 300MG | CAPSULE | Resolved | 2018-04-02 | 2018-08-21 | 44497 |
APO-LITHIUM CARBONATE | 300MG | CAPSULE | Resolved | 2018-05-15 | 2018-09-11 | 49367 |
APO-IRBESARTAN | 300MG | TABLET | Resolved | 2018-05-15 | 2018-09-11 | 49408 |
APO-IRBESARTAN | 300MG | TABLET | Avoided shortage | 2018-07-15 | 2018-08-21 | 55810 |
APO-TENOFOVIR | 300MG | TABLET | Resolved | 2018-07-25 | 2018-09-04 | 56538 |
APO-QUETIAPINE | 300MG | TABLET | Resolved | 2018-07-31 | 2018-09-28 | 56989 |
APO-CLINDAMYCIN | 300MG | CAPSULE | Resolved | 2018-08-09 | 2018-10-26 | 57779 |
APO-ABACAVIR | 300MG | TABLET | Resolved | 2018-11-16 | 2019-01-23 | 67019 |
APO-ALLOPURINOL | 300MG | TABLET | Resolved | 2019-01-30 | 2019-02-13 | 74014 |
APO-CLINDAMYCIN | 300MG | CAPSULE | Resolved | 2019-02-06 | 2019-04-25 | 74867 |
APO-DILTIAZ CD | 300MG | CAPSULE (CONTROLLED-DELIVERY) | Resolved | 2019-03-05 | 2019-11-05 | 77872 |
APO-IBUPROFEN | 300MG | TABLET | Resolved | 2019-06-05 | 2021-01-11 | 85597 |
APO-CLOPIDOGREL | 300MG | TABLET | Resolved | 2019-08-14 | 2019-10-15 | 91532 |
APO-RANITIDINE TABLET 300MG | 300MG | TABLET | Actual shortage | 2019-09-18 | 2019-09-18 | 94177 |
APO-OXCARBAZEPINE | 300MG | TABLET | Resolved | 2020-06-17 | 2022-02-09 | 118046 |
APO-ALLOPURINOL | 300MG | TABLET | Resolved | 2020-07-23 | 2021-05-17 | 120971 |
APO-TENOFOVIR | 300MG | TABLET | Resolved | 2020-09-30 | 2020-11-16 | 125338 |
APO-PREGABALIN | 300MG | CAPSULE | Resolved | 2020-10-21 | 2020-11-28 | 126771 |
APO-GABAPENTIN | 300MG | CAPSULE | Resolved | 2021-01-22 | 2021-01-27 | 132355 |
APO-LAMIVUDINE | 300MG | TABLET | Resolved | 2021-02-26 | 2021-06-28 | 134757 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-AMOXI SUGAR FREE | 125MG | POWDER FOR SUSPENSION | Discontinued | 2018-09-07 | 2018-09-15 | 60249 |
APO NAPROXEN TAB 125MG | 125MG | TABLET | Discontinued | 2018-09-08 | 2019-08-08 | 60663 |
APO-HYDROMORPHONE CR | 12MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110962 |
APO-NIZATIDINE | 150MG | CAPSULE | Discontinued | 2017-03-13 | 2017-03-13 | 1127 |
APO-SULIN TAB 150MG | 150mg | tablet | Discontinued | 2017-03-13 | 2017-03-13 | 1186 |
APO-CLINDAMYCIN | 150MG | CAPSULE | To be discontinued | 2018-09-07 | 2018-12-28 | 60396 |
APO-IRBESARTAN | 150MG | TABLET | Discontinued | 2018-09-07 | 2018-12-28 | 60536 |
APO-LAMIVUDINE | 150MG | TABLET | Discontinued | 2018-09-07 | 2019-07-13 | 60557 |
APO-RANITIDINE TABLET 150MG | 150MG | TABLET | Discontinued | 2018-09-08 | 2019-02-13 | 60723 |
APO-RANITIDINE TABLET 150MG | 150MG | TABLET | Discontinued | 2018-09-08 | 2018-12-28 | 60726 |
APO-RANITIDINE TABLET 150MG | 150MG | TABLET | Discontinued | 2019-01-02 | 2019-01-09 | 70810 |
ACID REDUCER | 150MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71210 |
APO-IRBESARTAN | 150MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71234 |
APO-CLINDAMYCIN | 150MG | CAPSULE | Discontinued | 2019-11-11 | 2019-11-11 | 98363 |
APO-OXAZEPAM | 15MG | TABLET | To be discontinued | 2018-09-08 | 2018-09-08 | 60678 |
APO-TEMAZEPAM | 15MG | CAPSULE | Discontinued | 2018-10-23 | 2019-01-14 | 65477 |
APO-PINDOL TAB 15MG | 15MG | TABLET | Discontinued | 2022-02-09 | 2022-12-09 | 154574 |
APO-SOTALOL | 160MG | TABLET | Discontinued | 2017-03-31 | 2018-02-05 | 4971 |
APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60313 |
APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60316 |